Amedeo Smart

Free Medical Literature Service

 

Amedeo

Inflammatory Bowel Diseases
  Free Subscription

Articles published in
N Engl J Med
    August 2023

  1. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2023;389:772.
    >> Share

    June 2023
  2. D'HAENS G, Dubinsky M, Kobayashi T, Irving PM, et al
    Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2023;388:2444-2455.
    >> Share

    May 2023
  3. ABREU MT
    JAK1 Inhibition to Treat Crohn's Disease.
    N Engl J Med. 2023;388:2005-2009.
    >> Share

  4. LOFTUS EV JR, Panes J, Lacerda AP, Peyrin-Biroulet L, et al
    Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
    N Engl J Med. 2023;388:1966-1980.
    >> Share

    March 2023
  5. TRAVIS S, Silverberg MS, Danese S, Gionchetti P, et al
    Vedolizumab for the Treatment of Chronic Pouchitis.
    N Engl J Med. 2023;388:1191-1200.
    >> Share

    April 2022
  6. KOTHARI R, Vashisht D
    Knife-Cut Ulcers in Crohn's Disease.
    N Engl J Med. 2022;386:e37.
    >> Share

    January 2022
  7. ZANGER K, Nimkin K, Israel EJ, Shih AR, et al
    Case 3-2022: A 14-Year-Old Boy with Fever, Joint Pain, and Abdominal Cramping.
    N Engl J Med. 2022;386:375-383.
    >> Share

  8. SANDBORN WJ, Danese S
    Ozanimod for Ulcerative Colitis. Reply.
    N Engl J Med. 2022;386:194-195.
    >> Share

  9. SENUSSI NH, Rakov N
    Ozanimod for Ulcerative Colitis.
    N Engl J Med. 2022;386:194.
    >> Share

  10. MACALUSO FS, Orlando A
    Ozanimod for Ulcerative Colitis.
    N Engl J Med. 2022;386:194.
    >> Share

    November 2021
  11. PETRUZZI M, Della Vella F
    Pyostomatitis Vegetans.
    N Engl J Med. 2021;385:e77.
    >> Share

    September 2021
  12. BAUMGART DC, Le Berre C
    Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease.
    N Engl J Med. 2021;385:1302-1315.
    >> Share

  13. SANDBORN WJ, Feagan BG, D'Haens G, Wolf DC, et al
    Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2021;385:1280-1291.
    >> Share

    August 2021
  14. SCHETT G, McInnes IB, Neurath MF
    Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs.
    N Engl J Med. 2021;385:628-639.
    >> Share

    April 2021
  15. CHANG JT
    Pathophysiology of Inflammatory Bowel Diseases. Reply.
    N Engl J Med. 2021;384:1378.
    >> Share

  16. MRAVEC B
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1377-1378.
    >> Share

  17. GAFFNEY P, Gaffney R
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1377.
    >> Share

  18. CHEN CJ, Hu H, Liao WT
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2021;384:1376-1377.
    >> Share

    February 2021
  19. THOMAS AS, Ma W, Wang Y
    Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors.
    N Engl J Med. 2021;384:581-583.
    >> Share

    December 2020
  20. CHANG JT
    Pathophysiology of Inflammatory Bowel Diseases.
    N Engl J Med. 2020;383:2652-2664.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016